SF3B1 MUTATIONS IN MDS-RS ARISE IN MULTIPOTENT HEMOPOETIC STEM CELLS

被引：0
|
作者：
Mortera-Blanco, T. [1 ]
Dimitriou, M. [1 ]
Woll, P. S. [2 ]
Elvarsdottir, E. [1 ]
Karimi, M. [1 ]
Conte, S. [1 ]
Jansson, M. [1 ]
Douagi, I. [1 ]
Papaemmanuil, E. [3 ]
Jacobsen, S. E. [1 ,2 ]
Hellstrom-Lindberg, E. [1 ]
机构：
[1] Karolinska Univ Hosp Huddinge, Ctr Hematol & Regenerat Med, Stockholm, Sweden
[2] Univ Oxford, Weatherall Inst Mol Med, Haematopoiet Stem Cell Biol Lab, Oxford, England
[3] Wellcome Trust Sanger Inst, Canc Genome Project, Cambridge, England
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
S445
引用
收藏
页码：159 / 159
页数：1
相关论文
共 50 条
  • [31] The Clonal Trajectories of SF3B1 Mutations in Myeloid Neoplasia
    Awada, Hassan
    Kerr, Cassandra M.
    Adema, Vera
    Gurnari, Carmelo
    Pagliuca, Simona
    Rogers, Heesun J.
    Carraway, Hetty E.
    Sekeres, Mikkael A.
    Maciejewski, Jaroslaw P.
    Visconte, Valeria
    BLOOD, 2020, 136
  • [32] CHARACTERIZATION OF CHARACTERISTIC MORPHOLOGICAL ALTERATIONS IN PATIENTS WITH MDS/CMML AND GENE MUTATIONS OF SPLICING DIFFERENT TO SF3B1
    Marco Ayala, J.
    Senent Peris, M. L.
    Vicente, A., I
    Saumell, S.
    Such, E.
    Blanco, A.
    Diaz, A.
    Luna, I
    De la Puerta, R.
    Sanz, G.
    HAEMATOLOGICA, 2019, 104 : 290 - 290
  • [33] SF3B1 mutations in MDS subgroups and s-AML and their association with cytogenetics and other molecular markers
    Jeromin, S.
    Dicker, F.
    Meggendorfer, M.
    Eder, C.
    Grossmann, V.
    Kohlmann, A.
    Kern, W.
    Haferlach, C.
    Haferlach, T.
    Schnittger, S.
    LEUKEMIA RESEARCH, 2013, 37 : S11 - S11
  • [34] Genetic characterization of SF3B1 mutations in single chronic lymphocytic leukemia cells
    X Wu
    R C Tschumper
    D F Jelinek
    Leukemia, 2013, 27 : 2264 - 2267
  • [35] Molecular Evaluation of SF3B1 Mutations in Cytopenic Patients
    Goyal, B.
    Duncavage, E. J.
    MODERN PATHOLOGY, 2013, 26 : 329A - 330A
  • [36] A Murine Model Harboring Cooperating DNMT3A and SF3B1 Mutations Phenocopies SF3B1 Driven Myelodysplastic Syndrome
    Wallace, Lashanale
    Leal-Cervantes, Ana
    Metidji, Amina
    Myers, Jacquelyn
    Rolle, Chandra
    Tillman, Heather
    Obeng, Esther A.
    BLOOD, 2022, 140 : 5862 - 5863
  • [37] Distinct methylation signature in MDS patients with SF3B1 mutations confers a novel mechanism of disease pathogenesis
    Visconte, V.
    Zhang, L.
    Mahfouz, R.
    Tabarroki, A.
    Rogers, H. J.
    Hasrouni, E.
    Hamilton, B.
    Jankowska, A.
    Barnard, J.
    Traina, F.
    Duong, H.
    Saunthararajah, Y.
    Lichtin, A.
    Horwitz, L.
    Sekeres, M. A.
    Tiu, R. V.
    LEUKEMIA RESEARCH, 2013, 37 : S27 - S27
  • [38] SF3B1-initiating mutations in MDS-RSs target lymphomyeloid hematopoietic stem cells
    Mortera-Blanco, Teresa
    Dimitriou, Marios
    Woll, Petter S.
    Karimi, Mohsen
    Elvarsdottir, Edda
    Conte, Simona
    Tobiasson, Magnus
    Jansson, Monika
    Douagi, Iyadh
    Moarii, Matahi
    Saft, Leonie
    Papaemmanuil, Elli
    Jacobsen, Sten Eirik W.
    Hellstrom-Lindberg, Eva
    BLOOD, 2017, 130 (07) : 881 - 890
  • [39] Molecular Evaluation of SF3B1 Mutations in Cytopenic Patients
    Goyal, B.
    Duncavage, E. J.
    LABORATORY INVESTIGATION, 2013, 93 : 329A - 330A
  • [40] Genetic characterization of SF3B1 mutations in single chronic lymphocytic leukemia cells
    Wu, X.
    Tschumper, R. C.
    Jelinek, D. F.
    LEUKEMIA, 2013, 27 (11) : 2264 - 2267
12345